Entrada Therapeutics
TRDA
$13.16
Share price
-2.95%
Change (1 day)
10.13%
Change (1 year)
Categories
P/S ratio for Entrada Therapeutics (TRDA)
P/S ratio as of May 2024 (TTM): 3.54
According to Entrada Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.53974. At the end of 2023 the company had a P/S ratio of 3.90.
P/S ratio history for Entrada Therapeutics from 2021 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 3.90 | |
| 2022 | N/A | |
| 2021 | N/A |